The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial

GaPs was conducted as part of the Pertussis Correlates Of Protection Europe (PERISCOPE) consortium, which received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement 115910. This Joint Undertaking receives support from the EU's Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations, and the Bill & Melinda Gates Foundation.

Authors

Institutions

Publication Details

Journal
The Lancet Infectious Diseases
Published
2025-03-27
DOI
https://doi.org/10.1016/s1473-3099(25)00072-6
Citations
9
Primary Topic
Bacterial Infections and Vaccines
Type
article
Field-Weighted Citation Impact
10.65

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial

Anja Saso, Ebrima Kanteh, Kiarash Tanha, Qiushui He et al.
9 citations
The Lancet Infectious Diseases
Bacterial Infections and Vaccines
10.65
article

The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial

Anja Saso, Ebrima Kanteh, Kiarash Tanha, Qiushui He, Elishia Roberts, Breeze E. Cavell, Alex‐Mikael Barkoff, Janeri Fröberg, Dimitri Diavatopoulos, Nuredin Mohammed, Anne‐Marie Buisman, Amadou Faal, Pieter G. M. van Gageldonk, Sophie Roetynck, David Jeffries, Sagida Bibi, Beate Kampmann, E. Lesné, Michael Okoye, Dominic F. Kelly, Michelle Kumado, Haddijatou Jobe
article en
9 citations

Abstract

GaPs was conducted as part of the Pertussis Correlates Of Protection Europe (PERISCOPE) consortium, which received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement 115910. This Joint Undertaking receives support from the EU's Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations, and the Bill & Melinda Gates Foundation.

The Lancet Infectious DiseasesVol. 25(8)
University of Turku (FI), Richmond University Medical Center (US), University of Oxford (GB), Yeshiva of Greater Washington (US), Ospedale di Rivoli (IT), National Institute for Public Health and the Environment (NL), MRC Unit the Gambia (GM), Maine Farmland Trust (US), Mangalam Research Center for Buddhist Languages (US), National Research Institute for Veterinary Virology and Microbiology of Russia (RU), UK Health Security Agency (GB)
Bill and Melinda Gates Foundation, Wellcome Trust, European Federation of Pharmaceutical Industries and Associations, Innovative Medicines Initiative, Medical Research Council
Good health and well-being
Openalex Percentile: Top 1%
Bacterial Infections and Vaccines
10.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.